Autoimmunity Reviews

Article	Citations
“Fibromyalgia syndrome” related to Essure devices	297
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	185
Editorial Board	152
Editorial Board	133
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	114
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	109
Editorial Board	94
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	89
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	86
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	80
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	79
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	76
Susac syndrome: A scoping review	75
Endometriosis and autoimmunity	75
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	75
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome	73
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	73
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	72
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	71
Editorial Board	69
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	69
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	63
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	62
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 24	61
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	60

Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	55
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	54
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	53
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	53
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	52
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	52
Can anticoagulation be withdrawn in APS patients after aPL negativization?	50
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	50
Autoimmunity in vitiligo: Therapeutic implications and opportunities	49
Psychiatric manifestations of autoimmune encephalitis	47
Seronegative autoimmune diseases: A challenging diagnosis	45
Autoimmune pre-disease	45
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	45
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	44
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	43
Editorial Board	42
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	42
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	42
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	42
A descriptive study of IgG4-related disease in children and young adults	42
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	42
Editorial Board	41
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	40
Adipose failure through adipocyte overload and autoimmunity	39
SpA plus IBD or IBD plus SpA: Does commutative property apply?	39
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	39
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	39
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	38
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	38
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	37
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	37
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	37
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	36
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	36
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database	36
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	36
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	35
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases	35
Editorial Board	35
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	34
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	34
Fibromyalgia: Are we using the biopsychosocial model?	34
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	34
Chronic inflammation in Long COVID relationship to autoimmune diseases	33
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	33
The role of mitochondrial dysfunction in kidney injury and disease	31
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	31
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	30
The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function	30
Tumor necrosis factor-α inhibitor-related autoimmune disorders	30

Development of an algorithm for IgG4-related disease management	30
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	29
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	29
Are IF-ANA the guiding light for SLE classification in the real-world setting?	28
Editorial Board	28
Reply letter to letter to the editor	28
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	27
Editorial Board	27
Editorial Board	27
Anti-rods/rings autoantibodies in a patient with pancreatic injury	27
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	27
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	27
Twenty shades of the mosaic of autoimmunity	27
Alarmins in autoimmune diseases	27
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	26
Mucous membrane pemphigoid	26
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	26
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	26
Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis	26
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy	26
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	26
Cutting edge confusion about cut-off settings in autoimmune diagnostics	25
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	25
In Memoriam: Pierre Youinou	25
Neuroimaging in thyroid eye disease: A systematic review	25
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	24
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	24
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	24
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	24
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	24
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	24
Editorial Board	24
Diagnostic approach in giant cell arteritis	23
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	23
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	23
Editorial Board	23
Serum calprotectin is a marker of disease activity in Giant cell arteritis	23
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	23
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	22
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	22
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	22
Is it time for treat-to-target in antiphospholipid syndrome?	22
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	22
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	22
Persistent aortic inflammation in patients with giant cell arteritis	21
JAK inhibitors and systemic sclerosis: A systematic review of the literature	21
Editorial Board	21
From inflammation to renal fibrosis: A one-way road in autoimmunity?	21
Inflammatory muscle involvement in systemic vasculitis: A systematic review	21
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	21
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	21
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	21
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	21
Salivary gland involvement in ANCA-associated vasculitis	21
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	21
Don't mix apples and oranges. Reply to Azoulay et al.	21
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	20
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	20
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	20
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	20
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	20
Editorial Board	20
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	20
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	20
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	20
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	20
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	19
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	19
Rapid radiographic progression in rheumatoid arthritis: Definition, prediction and treatment	19
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	19
Intermittent fasting: A promising dietary intervention for autoimmune diseases	19
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	19
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	18
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	18
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	18
Involvement of aquaporin 5 in Sjögren’s syndrome	18
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	18
Insights into new-onset autoimmune diseases after COVID-19 vaccination	18
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis	18
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	17

Emerging roles of mechanically activated ion channels in autoimmune disease	17
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	17
Editorial Board	17
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	17
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	17
Anti-glomerular basement membrane vasculitis	17
Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis	17
Prevention of rheumatoid arthritis using a familial predictive medicine approach	17
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	17
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	17
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations	17
Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review	16
Outcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases	16
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus	16
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain	16
Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence	16
Exploring vaccine safety and adverse events in major autoimmune diseases	16
Editorial Board	16
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies	15
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies	15
Effect of exercise training on fatigue and pain in patients with systemic autoimmune myopathies: A systematic review	15
Relapses in giant cell arteritis: Updated review for clinical practice	15
Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis	15
Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options	15
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis	15
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Iss	14
Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?	14
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?	14
Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions	14
The role of γδ T cells and CAR-γδ T cell therapy in autoimmune diseases	14
The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammation	14
Macrophage metabolic reprogramming: A trigger for cardiac damage in autoimmune diseases	14
Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using highly multiplexed imaging mass cytometry	13
The role of interleukin inhibitors in the treatment of hidradenitis suppurativa; a systematic review of clinical trials	13
Building a monitoring matrix for the management of multiple sclerosis	13
Macrophage polarization regulates the pathogenesis and progression of autoimmune diseases	13
Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation	13
Letter to the editor: Keratitis fugax hereditaria is an eye-specific cryopyrin-associated periodic syndrome	13
Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets	13
B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis	13
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and exper	13
Intravenous immunoglobulin as a therapy for autoimmune conditions	13
Editorial Board	13
Exposome: Epigenetics and autoimmune diseases	13
Single centre experience of 120 patients with non-infectious aortitis: Clinical features, treatment and complications	13
Efficacy, safety, and tolerability of antifibrotic agents in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	12
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review	12
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprinting	12
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort	12
Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications	12
Residual pain in rheumatoid arthritis: Is it a real problem?	12
Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides	12
Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019	12
Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype	12
Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?	12
Association between breastfeeding and the risk of autoimmune diseases: A systematic review and meta-analysis	12
Short-term and low-dose IL-2 therapy increases the reduced Treg cells in patients with microscopic polyangiitis	12
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus	12
COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis	12
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases	12
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis	12
Effects of nutritional supplements and dietary interventions on rheumatoid arthritis: An umbrella review of meta-analyses of randomized controlled trials	12
ChatGPT and autoimmunity – A new weapon in the battlefield of knowledge	12
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force	11
Social determinants of health and disparities across the Patient pathway in Systemic Lupus Erythematosus: a narrative review	11
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts	11
Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019	11
Key points to consider for an improved detection and characterization of cryoglobulins	11
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation	11
Aquaporins: Unexpected actors in autoimmune diseases	11
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19	11
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience	11
Renal involvement in systemic sclerosis	11
SLE patients with childhood-onset: A nation-wide population-based study	11
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus	11
Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues	11
Editorial Board	11
Global analysis of antiphospholipid syndrome and stroke research: identifying emerging trends, international collaborations, and knowledge gaps	10
Managing the clinical heterogeneity of patients with Still's disease, from early diagnosis to timely treatment	10
Experiences and unmet needs of persons living with systemic lupus erythematosus in Europe: Lupus Europe's 2024 Swiss knife survey	10
Renal autoimmunity: The role of bacterial and viral infections, an extensive review	10
Non-invasive imaging in antiphospholipid syndrome to assess subclinical coronary artery disease	10
Health inequalities and social determinants of health: The role of syndemics in rheumatic diseases	10
Editorial Board	10
Reflecting on a decade of the international consensus on ANA patterns (ICAP): Accomplishments and challenges from the perspective of the 7th ICAP workshop	10
Pathogenesis-based new perspectives of management of ANCA-associated vasculitis	10
Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis	10
Lung involvement in juvenile idiopathic inflammatory myopathy: A systematic review	10
Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidence	10
Editorial Board	10
Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic	10
The role of B cells in Sjögren's syndrome and their impact on the nervous system	10
Letter to the editor: Prevalence of connective tissue disease autoantibodies in a large longitudinal population-based cohort from the Netherlands	10
Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?	10
Editorial Board	10